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ABSTRACT
O b je c t i v e :  Upper respiratory disorders such as 
allergic rhinitis and rhinosinusitis are different 
facets of a larger systemic inflammatory 
syndrome involving both the upper and lower 
airways. Effective treatment of sinonasal 
disease, which is one of the factors that 
exacerbate asthma, may also improve and 
stabilize the asthmatic condition. Patients with 
persistent asthma should be searched for 
otorhinolaryngologic disorders. The aim of this 
study was to determine whether there is a an 
association between asthma and otolaryngologic 
disorders.
M e t h o d s :  Forty-two asthmatic patients and 42 
controls were examined for otorhinolaryngologic 
disorders by the same physician. Data were 
compared in groups by using Fisher’s Exact Test.
R e s u l t s :  Eighty-nine percent of the asthmatic 
patients were shown to have associated 
otorhinolaryngologic disorders which is 
significantly higher than in the controls 
(42%),(p<0,0001).
Conclusion: Upper respiratory disorder is a very 
common comorbidity of asthma and common 
mechanisms exist. The nasal and sinus 
inflammation in asthmatics seems to be related
specifically to asthma and is not a feature of all 
bronchial diseases. The presence of upper 
respiratory disorders should always be 
investigated in adults with asthma. Treatment of 
nasal conditions confers significant protection 
against asthma exacerbations.
K ey W o rd s: Asthma, Allergy, Polyps, Vocal 
cord dysfunction, Posterior laryngitis, 
Candidiasis.
INTRODUCTION
Asthma is a chronic inflammatory disease of the 
lower respiratory tract which is triggered by 
exposure to allergens or other airway irritants. 
Even since the late 19th century, a relationship 
has been suspected between upper airway 
disease and the subsequent development or 
aggravation of asthma symptoms. To date, it has 
been generally accepted that pathologic 
conditions of the upper airways, e.g. allergic 
rhinitis, chronic sinusitis and nasal polyps, may 
influence the lower airways (1).
In this paper we investigate the most common 
otorhinolaryngologic disorders in asthmatic 
patients because of the interaction between the 
upper and lower respiratory systems.
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MATERIALS A N D  M ETHODS
Forty-two asthmatic and 42 nonasthmatic 
subjects were included in the study. The 
asthmatic subjects had stable symptoms at the 
time of the study, and no history within the 
preceding 2 months of respiratory infection, or 
antibiotic or oral corticosteroid use, and were 
treated only with inhaled bronchodilators. 
Asthma was defined according to the American 
Thoracic Society definition and all patients had 
mild or moderate asthma in this study (2). The 
average disease duration was 98,55 months (6- 
420 months). None of the nonasthmatic subjects 
had asthmatic symptoms or required inhalational 
therapy. The study was approved by the 
Marmara University Hospital Ethics Committee 
and written informed consent was obtained from 
each subject. There were 36 females and 6 
males in the asthmatic group and 15 males and 
27 females in the control group. The average age 
of the control subjects and asthmatics was 41 
years and 42,6 years respectively. There was 
not any difference between control and asthmatic
groups according to age and sex distribution. 
Ear, nose and throat (ENT) examination was 
performed in these two groups by same 
physician. Asthmatic patients and controls were 
examined by anterior rhinoscopy and endoscopic 
investigation with a 0°rigid endoscope (Storz).
RESULTS
The data were compared in groups between 
patients with bronchial asthma and those without 
(control group), using Fisher's Exact Test. A ‘p' 
value <0,05 was considered significant. We 
found that 98% of the asthmatic patients had 
otorhinolaryngologic disorders and this was 
significantly higher than in the controls (42%), 
(p<0,0001) (Fig 1). The highest prevalence of 
otorhinolaryngologic disorder was posterior 
laryngitis (p<0.0001). Other otorhinolaryngologic 
disorders observed in this study were polyps 
(p :0.1160, p>0,05), candidiasis (p:0.4940,
p>0,05), chronic pharyngitis (p:0,0072, p<0.01), 
septal deviation (p:0,999, p>0,05), vocal cord
OTORHINOLARYNGOLOGIC DISORDERS IN ASTHMATIC PATIENTS AND CONTROLS
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F ig . 1 : Otorhinolaryngologic disorders in asthmatic patients and control. Polyps, Septal deviation, Chronic pharyngitis, Turbinate 
hypertrophy, Candidiasis, Posterior laryngitis and VCD= Vocal Cord Dysfunction were otolaryngologic disorders which have 
been determined in this study.
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dysfunction p:(0,4940, p>0,05) and turbinate 
hypertrophy (p:0,1163, p>0,05) were other 
otorhinolaryngologic disorders which have been 
determined in this study (Figs 2, 3).
□  n o r m a l
■  p o l y p s
B  s e p t a l  d e v i a t i o n
■  c h r o n i c  p h a r y n g i t i s
□  t u r b i n a t e  h y p e r t r o p h y
■  c a n d i d i a s i s
□  p o s t e r i o r  l a r y n g i t i s
■  V C D ’
F .g .2  : Distribution of otorhinolaryngologic disorders in the 
control group. *VCD= Vocal Cord Dysfunction. 48% of 
controls have normal findings of ENT examination.
F ig .3 :  D istribution of o torh inolaryngologic disorders in 
asthmatic patient. In asthmatic group most common 
otolaryngologic disorder is posterior laryngitis in this 
study.
DISCUSSION
The upper airways--the nose, pharynx, and 
mouth-lead through the larynx and Into the 
tracheobronchial tree of the lung (the lower 
airways). This cavernous void in the upper 
airways transports external air to the alveolar 
sacs, in the distal segments of the 
tracheobronchial tree. Under adverse physiologic 
conditions such as allergic or nonallergic rhinitis, 
sinusitis, and bronchitis, obstruction of the upper 
and lower airways occurs and leads to sneezing, 
rhinitis, and bronchospasm (3).
In a recent report from the American Academy of 
Allergy, Asthma and Immunology, it was
estimated that up to 78% of asthma patients 
have nasal symptoms and 38% of allergic rhinitis 
patients have asthma (4). This is in accordance 
with the results from an analysis of the European 
Community Respiratory Health Survey data, 
showing that rhinitis is associated with an 
increased risk of asthma in nonatopic subjects 
with normal immunoglobulin-E levels (5). 
Patients with allergic rhinitis exhibit increased 
eosinophil activity in both upper and lower 
airways. In these patients, nasal allergen 
challenge can induce increased bronchial 
hyperresponsiveness, suggesting that upper and 
lower airway disorders share common 
inflammatory features. Treatment of rhinitis 
symptoms has been shown to produce better 
asthma symptom control and, in a few studies, 
the improvement of airway function in patients 
with concomitant asthma. In dosages used to 
treat allergic rhinitis, these agents have been 
shown to decrease asthma symptoms, and in 
some instances, improve lung function and 
reduce requirements for bronchodilators (6-9). In 
this study we determined that asthmatic patients 
have more allergies than controls (p< 0,0001). 
Turbinate hypertrophy and septal deviation were 
determined in asthmatic patients more than in 
controls but were statistically insignificant 
(p:0,1163), (p:0,999).
Whenever individuals with asthma get a sinus 
infection, the asthma worsens. When 
accompanied by a sinus infection, the asthma 
cannot be treated with simple drugs. When the 
nose obstructs, these individuals breathe with the 
mouth open, which precipitates an asthma 
attack. Possible mechanisms by which asthma 
could be worsened by sinus disease include 
neural reflex pathways and interference with the 
important nasal functions of heating, 
humidification, and filtration. Patients with 
asthma have a dry mouth all the time and are 
bothered by thick nasal phlegm dripping into the 
throat. The thick phlegm causes these patients to 
cough and try to clear the throat constantly. 
These pharyngeal irritations cause chronic 
pharyngitis. In this study we determined that 
asthmatic patients have chronic pharyngitis more 
than controls (p<0,01).
Myofibroblasts are related to airway remodelling 
and may play an important role in the 
pathogenesis of the histological features of nasal
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polyps associated with asthma (10). In many 
studies it vas demonstrated that endoscopic 
sinus surgery (ESS) has a favorable effect on 
asthma in patients with symptomatic chronic 
sinusitis and polyps (11). In this study we 
recommended ESS for 4 asthmatic patients with 
polyps and chronic sinusitis (12).
In addition to the above factors, recognition of 
laryngopharyngeal reflux (LFR) as an irritant that 
brings on asthmatic symptoms, as well as throat 
and laryngeal symptoms, is increasing (13). 
When the larynx was viewed with a mirror or 
endoscope, the arytenoids were observed to be 
inflamed, especially posteriorly. In this study, 
posterior laryngitis was determined more than in 
controls (p<0.0001) and we started medical 
therapy for LFR. Vocal cord dysfunction (VCD) 
can be characterized as an abnormal adduction 
of the vocal cords during the respiratory cycle 
(especially during the inspiratory phase) that 
produces airflow obstruction at the level of the 
larynx. VCD frequently mimics persistent asthma 
and is often treated with high-dose inhaled and/or 
systemic corticosteroids, bronchodilators, 
multiple ED visits, hospitalization, and, in some 
cases, tracheotomies and intubations. The 
various etiologies include cortical injury involving 
either upper or lower motor neurons, brainstem 
compression, conversion disorder, malingering, 
and irritant induced such as laryngopharyngeal 
reflux (14). In this study two patients were 
determined with VCD. One of these patients was 
a 55-year-old woman with paradoxical vocal cord 
adduction who presented with asthmatic 
symptoms as wheezing and stridor. She had 
been treated for bronchial asthma without any 
improvement. After laryngeal examination with 
70° rigid endoscope (Storz), we observed 
posterior laryngitis with dysfunctional vocal cord 
movement induced by laryngopharyngeal reflux. 
After laryngopharyngeal reflux treatment during 6 
months, the respiratory symptoms were 
dissolved. Another patient with VCD who 
presented with asthmatic symptoms was a 51- 
year-old woman. She had laryngopharyngeal 
reflux and psychological problems. In addition to 
medical treatment for LFR and consultation at the 
Department of Psychiatry, we started to teach 
her diaphragmatic breathing exercises. Her 
respiratory symptoms partially dissolved after 
initial therapy of one month's duration. Now, she 
is on follow up visits.
Inhaled steroids such as fluticasone propionate 
and beclomethasone dipropionate play a central 
role in the treatment of bronchial asthma. One of 
the previous studies reported that the amount of 
Candida spp. was significantly greater in 
asthmatic patients taking inhaled steroids 
compared with those who were not (15).The 
most common drug-related adverse events were 
those expected with the administration of topical 
inhaled glucocorticosteroids (oropharyngeal 
candidiasis and dysphonia), and they occurred at 
higher incidences in the inhaled fluticasone 
propionate treatment groups than in the placebo 
or oral fluticasone propionate treatment groups 
(16). In this study after the ENT examination we 
determined oropharyngeal candidiasis in two 
asthmatic patients and we applied antimycotic 
treatment.
The epidemiologic and clinical studies have 
shown that there is a strong relationship between 
upper airway pathology and asthma. The 
mechanisms of nasobronchial interaction have 
been discussed intensively and most recent 
studies provided proofs in favor of a systemic 
pathway, involving bloodstream and bone 
marrow. The determinants of clinical phenotype 
in allergic airway disease is still not clear. 
Generalized airway inflammation is present in 
patients with allergic rhinitis, sinusitis and nasal 
polyposis, even in the absence of clinical asthma. 
Further studies are needed to show that these 
subjects represent a group at risk for the 
development of asthma.
REFERENCES
1. Canonica GW. Introduction to nasal and  
pulm onary allergy cascade. Allergy 2 0 0 2 ;57  
Suppl 75:8-12.
2. American Thoracic Society.Standards for the 
diagnosis and care o f patients with chronic 
obstructive pulm onary disease (COPD) and  
asthma.Am Rev Respir Dis 1987; 136:225- 
234.
3. Glovsky MM. Upper airways involvem ent in 
bronchia! asthm a. Curr Opin Pulm M ed  
1998;4:54-58.
4. rio authors listed. O verview  o f  allergic
diseases: Diagnosis, m anagem ent, and
barriers to care. The Allergy Report; Vol. I. 
Milwaukee, Wl: American Academ y o f Allergy, 
Asthma Sr Immunology; 2000 .
264
A s th m a  a n d  o t o r h in o la r y n g o lo g i c  d is o rd e rs
5. M ontne'm ery P, Hi hie n U, Lo" fdahl CG, et al. 
The association between asthma, chronic 
bronch itis /em physem a and  rhinitis, bur 
Respir J  2001  ; 18 Suppi:33:201s.
6. Casale TB. Im m unobiology o f asthma and
rhinitis: pathogenic factors and therapeutic 
options. In: A m erican Thoracic Society
W orkshop Sum m ary, Montreal, Quebec, 
Canada, 1997. Hew York: American Lung 
Association, 1999.
7. Spector 5, Lee H, McHutt B, et al. Effect o f 
terfenadine in asthmatic patients. Ann Allergy 
1992 ;69 :212 -216 .
8. Bousquet J, Em onot A, Germouty J,et at. 
Double-blind m ulticentre study o f cetirizine in 
grass-po lleninduced asthm a. Ann Allergy 
1990 ;10 :504 -508 .
9. Spector SL, Hicodemus CE, Corren J, et a l  
Comparison o f the bronchodilatory effects o f 
cetirizine, albuterol, and both together versus 
placebo in patients with m ild-tom oderate  
asthma. J Allergy Clin Im m unol 1995;96:1 74- 
181.
10. flaruna S, Hakanishi PI, Otori H, Moriyama li. 
Histopathological features o f nasal polyps 
with asthm a association: an
im m unohistochem ical study. Am J  Rhinol 
2 0 0 4 ;1 8 :1 6 5 -1 7 2 .
11. Batra PS, Kern RC, Tripathi A, et al. Outcome 
analysis o f  endoscopic sinus surgery in 
patients with nasal polyps and asthma. 
Laryngoscope 20 0 3 ; 113:1 703-1 706.
12. Ragab A, Clement P, Vincken W. Objective 
assessment o f lower airway involvem ent in 
chronic rhinosinusitis. Am J  Rhinol 
2004;18 :15 -21 .
13. Perkner JJ, Eennelly KP, Balkissoon R, et al. 
Irritant associated vocal cord dysfunction. J 
Occup Environ Med 1 9 9 8 ;2 :136-144.
14. Altman KW, Simpson CB, Amin M, et al. 
Cough and paradoxical vocal fold motion. 
Otolaryngol Head Heck Surg 20 0 2 ; 127:501- 
511.
15. Fukushima C, Matsuse H, Tomari S, et al. Oral 
candidiasis associated with inhaled  
corticosteroid use: comparison o f  fluticasone 
and beclomethasone. Ann Allergy Asthma 
Im m unol 2 0 03 ;90 :646 -651 .
16. Lawrence M, Wolfe J, Webb DR, et al. Efficacy 
o f inhaled fluticasone propionate in asthma 
results from topical and not from systemic 
activity. Am J  Respir Crit Care Med 
1997 ; 156(3 Pt 1):744-751.
265
